Literature DB >> 20846582

Diagnosis of acute Q fever with emphasis on enzyme-linked immunosorbent assay and nested polymerase chain reaction regarding the time of serum collection.

Katharina Boden1, Christiane Wagner-Wiening, Thomas Seidel, Michael Baier, Wolfgang Bischof, Eberhard Straube, Peter Kimmig.   

Abstract

A commercially available enzyme-linked immunosorbent assay (ELISA) (Virion/Serion [Wuerzburg, Germany]), an indirect fluorescent antibody test (IFAT) (BIOS/Focus [Cypress, CA]), and a nested polymerase chain reaction (PCR) were explored for diagnosis of acute Q fever in reference to time of serum collection. Serum samples of 22 patients with acute Q fever collected around the fifth day of illness were included. A sensitivity of 30% by ELISA and 80% by IFAT (P = 0.1) was found for the first 5 days of illness and 92% by ELISA and 83% by IFAT during the sixth and eleventh day. PCR revealed a positive result in 8 cases (36%) with 6 cases deriving from the first 5 days of illness. We conclude that ELISA aids especially in the diagnosis of Q fever after 5 days of illness. The benefit of PCR as an additional tool to ELISA was especially evident in the early days of serum sampling.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20846582     DOI: 10.1016/j.diagmicrobio.2010.06.001

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  9 in total

1.  Immuno-PCR for the early serological diagnosis of acute infectious diseases: the Q fever paradigm.

Authors:  N Malou; A Renvoise; C Nappez; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-01-10       Impact factor: 3.267

2.  Evaluation of commonly used serological tests for detection of Coxiella burnetii antibodies in well-defined acute and follow-up sera.

Authors:  M C A Wegdam-Blans; C C H Wielders; J Meekelenkamp; J M Korbeeck; T Herremans; H T Tjhie; H A Bijlmer; M P G Koopmans; P M Schneeberger
Journal:  Clin Vaccine Immunol       Date:  2012-05-23

3.  Unusual manifestations of acute Q fever: autoimmune hemolytic anemia and tubulointerstitial nephritis.

Authors:  Serdal Korkmaz; Nazif Elaldi; Mansur Kayatas; Mehmet Sencan; Esin Yildiz
Journal:  Ann Clin Microbiol Antimicrob       Date:  2012-05-18       Impact factor: 3.944

4.  Proteomics paves the way for Q fever diagnostics.

Authors:  Malgorzata Kowalczewska; Zuzana Sekeyová; Didier Raoult
Journal:  Genome Med       Date:  2011-07-30       Impact factor: 11.117

5.  Q fever among culling workers, the Netherlands, 2009-2010.

Authors:  Jane Whelan; Barbara Schimmer; Peter Schneeberger; Jamie Meekelenkamp; Arnold Ijff; Wim van der Hoek; Mirna Robert-Du Ry van Beest Holle
Journal:  Emerg Infect Dis       Date:  2011-09       Impact factor: 6.883

6.  Coxiella burnetii (Q fever) as a cause of community-acquired pneumonia during the warm season in Germany.

Authors:  M Schack; S Sachse; J Rödel; D Frangoulidis; M W Pletz; G U Rohde; E Straube; K Boden
Journal:  Epidemiol Infect       Date:  2013-11-20       Impact factor: 4.434

7.  First Identification and Description of Rickettsioses and Q Fever as Causes of Acute Febrile Illness in Nicaragua.

Authors:  Megan E Reller; Ijeuru Chikeka; Jeremy J Miles; J Stephen Dumler; Christopher W Woods; Orlando Mayorga; Armando J Matute
Journal:  PLoS Negl Trop Dis       Date:  2016-12-30

8.  Maternofetal consequences of Coxiella burnetii infection in pregnancy: a case series of two outbreaks.

Authors:  Katharina Boden; Andreas Brueckmann; Christiane Wagner-Wiening; Beate Hermann; Klaus Henning; Thomas Junghanss; Thomas Seidel; Michael Baier; Eberhard Straube; Dirk Theegarten
Journal:  BMC Infect Dis       Date:  2012-12-19       Impact factor: 3.090

9.  Clinical and epidemiological use of nested PCR targeting the repetitive element IS1111 associated with the transposase gene from Coxiella burnetii.

Authors:  Maria Angélica M M Mares-Guia; Alexandro Guterres; Tatiana Rozental; Michelle Dos Santos Ferreira; Elba R S Lemos
Journal:  Braz J Microbiol       Date:  2017-08-24       Impact factor: 2.476

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.